Nakandakari-Higa S, Walker S, Canesso MCC, et al
It received FDA approval in 2010 for treating HIV-related lipodystrophy, and ongoing studies continue to explore its applications in nerve damage recovery and early cognitive decline
Supports antioxidant defense systems
It has been also shown to upregulate mitochondrial transcription factor A (TFAM) (Sreekumar et al., 2016), known to play a crucial role in stabilizing mtDNA through the formation of nucleoids, which are important to counteract mtDNA release (Li F et al., 2020), which serve as markers of oxidative stress (e.g., Lei and Rao, 2022)
Key Peptides Kisspeptin-10, gonadorelin, and GLP-1 analogs have been the most studied peptides for stabilizing menstrual cycles, each acting on a different segment of the reproductive axis and providing unique advantages for symptoms such as irregular bleeding, mood fluctuations, and fatigue